The CovaStat™ line of Bio-Active Absorbable Hemostatic Sponges are made from a patented cross-linked bioactive matrix that supports and increases the clot's strength, and has been specially designed to concentrate the blood's naturally occurring clotting factors, thus reducing clotting time.
CovaStat™ is indicated in surgical procedures (other than ophthalmological and urological surgery) as an adjunct to hemostasis when control of bleeding by ligature or conventinoal procedures is ineffective or impractical.
Available in two sizes; 2in. x 2in., 4in. x 4in. click for more information on how to order
FDA Clearance Pending. Not for sale in U.S.A.
1) Covalon Technologies Ltd. Data on file. Gelfoam and Surgicel values were determined from literature sources, available upon request. All trademarks are the property of their respective owners.
The CovaStat™ line of Hemostatic Sponges are available through medical distributors. If your distributor does not carry CovaStat™ please contact us for distributor names or to order CovaStat™ clinical evaluation samples.
If you would like to distribute CovaStat™ please contact us for information. Download the brochure.
CovaStat™ Bio-Active Absorbable Hemostatic Sponges - When Speed Matters.
May 15, 2013Arab Health Magazine features SurgiClear article: The importance of wound dressings.
May 01, 2013Covalon’s ColActive Plus Receives Medicare Billing Codes in Advance of the Symposium on Advanced Wound Care in Denver